Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study

Background: Premorbid metabolic syndrome (pre-MetS) is a cluster of cardiometabolic risk factors characterised by central obesity, elevated fasting glucose, atherogenic dyslipidaemia and hypertension without established cardiovascular disease or diabetes. Community pharmacies are in an excellent pos...

Descripción completa

Detalles Bibliográficos
Autores: Via Sosa, Ma. de los Ángeles, Toro, Cristina, Travé i Mercadé, Pere, March Pujol, Marian
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2014
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/59463
Acceso en línea:https://hdl.handle.net/2445/59463
Access Level:acceso abierto
Palabra clave:Farmàcies
Serveis farmacèutics
Cribratge
Síndrome metabòlica
Malalties cardiovasculars
Factors de risc en les malalties
Diabetis
Drugstores
Pharmaceutical services
Medical screening
Metabolic syndrome
Cardiovascular diseases
Risk factors in diseases
Diabetes
id ES_7ea6bdcb5b836d585a3bad6a77b25ff7
oai_identifier_str oai:diposit.ub.edu:2445/59463
network_acronym_str ES
network_name_str España
repository_id_str
spelling Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive studyVia Sosa, Ma. de los ÁngelesToro, CristinaTravé i Mercadé, PereMarch Pujol, MarianFarmàciesServeis farmacèuticsCribratgeSíndrome metabòlicaMalalties cardiovascularsFactors de risc en les malaltiesDiabetisDrugstoresPharmaceutical servicesMedical screeningMetabolic syndromeCardiovascular diseasesRisk factors in diseasesDiabetesBackground: Premorbid metabolic syndrome (pre-MetS) is a cluster of cardiometabolic risk factors characterised by central obesity, elevated fasting glucose, atherogenic dyslipidaemia and hypertension without established cardiovascular disease or diabetes. Community pharmacies are in an excellent position to develop screening programmes because of their direct contact with the population. The main aim of the study was to determine the prevalence of pre-MetS in people who visited community pharmacies for measurement of any of its five risk factors to detect the presence of other risk factors. The secondary aims were to study the presence of other cardiovascular risk factors and determine patients" cardiovascular risk. Methods: Cross-sectional, descriptive, multicentre study. Patients meeting selection criteria aged between 18 and 65 years who visited participating community pharmacies to check any of five pre-MetS diagnostic factors were included. The study involved 23 community pharmacies in Catalonia (Spain). Detection criteria for pre-MetS were based on the WHO proposal following IDF and AHA/NHBI consensus. Cardiovascular risk (CVR) was calculated by Regicor and Score methods. Other variables studied were smoking habit, physical activity, body mass index (BMI), and pharmacological treatment of dyslipidemia and hypertension. The data were collected and analysed with the SPSS programme. Comparisons of variables were carried out using the Student"s T-test, Chi-Squared test or ANOVA test. Level of significance was 5% (0.05). Results: The overall prevalence of pre-MetS was 21.9% [95% CI 18.7-25.2]. It was more prevalent in men, 25.5% [95% CI 22.1-28.9], than in women, 18.6% [95% CI 15.5-21.7], and distribution increased with age. The most common risk factors were high blood pressure and abdominal obesity. About 70% of people with pre-MetS were sedentary and over 85% had a BMI ≥25 Kg/m2 . Some 22.4% had two metabolic criteria and 27.2% of patients with pre-MetS had no previous diagnosis. Conclusions: The prevalence of pre-MetS in our study (21.9%) was similar to that found in other studies carried out in Primary Care in Spain. The results of this study confirm emergent cardiometabolic risk factors such as hypertension, obesity and physical inactivity. Our study highlights the strategic role of the community pharmacy in the detection of pre-MetS in the apparently healthy population.BioMed Central2014info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/59463Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: http://dx.doi.org/10.1186/1471-2458-14-487BMC Public Health, 2014, vol. 14, num. 487http://dx.doi.org/10.1186/1471-2458-14-487cc-by (c) Via Sosa, Ma. de los Ángeles et al., 2014http://creativecommons.org/licenses/by/3.0/esinfo:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/594632026-05-27T06:46:51Z
dc.title.none.fl_str_mv Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study
title Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study
spellingShingle Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study
Via Sosa, Ma. de los Ángeles
Farmàcies
Serveis farmacèutics
Cribratge
Síndrome metabòlica
Malalties cardiovasculars
Factors de risc en les malalties
Diabetis
Drugstores
Pharmaceutical services
Medical screening
Metabolic syndrome
Cardiovascular diseases
Risk factors in diseases
Diabetes
title_short Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study
title_full Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study
title_fullStr Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study
title_full_unstemmed Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study
title_sort Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study
dc.creator.none.fl_str_mv Via Sosa, Ma. de los Ángeles
Toro, Cristina
Travé i Mercadé, Pere
March Pujol, Marian
author Via Sosa, Ma. de los Ángeles
author_facet Via Sosa, Ma. de los Ángeles
Toro, Cristina
Travé i Mercadé, Pere
March Pujol, Marian
author_role author
author2 Toro, Cristina
Travé i Mercadé, Pere
March Pujol, Marian
author2_role author
author
author
dc.subject.none.fl_str_mv Farmàcies
Serveis farmacèutics
Cribratge
Síndrome metabòlica
Malalties cardiovasculars
Factors de risc en les malalties
Diabetis
Drugstores
Pharmaceutical services
Medical screening
Metabolic syndrome
Cardiovascular diseases
Risk factors in diseases
Diabetes
topic Farmàcies
Serveis farmacèutics
Cribratge
Síndrome metabòlica
Malalties cardiovasculars
Factors de risc en les malalties
Diabetis
Drugstores
Pharmaceutical services
Medical screening
Metabolic syndrome
Cardiovascular diseases
Risk factors in diseases
Diabetes
description Background: Premorbid metabolic syndrome (pre-MetS) is a cluster of cardiometabolic risk factors characterised by central obesity, elevated fasting glucose, atherogenic dyslipidaemia and hypertension without established cardiovascular disease or diabetes. Community pharmacies are in an excellent position to develop screening programmes because of their direct contact with the population. The main aim of the study was to determine the prevalence of pre-MetS in people who visited community pharmacies for measurement of any of its five risk factors to detect the presence of other risk factors. The secondary aims were to study the presence of other cardiovascular risk factors and determine patients" cardiovascular risk. Methods: Cross-sectional, descriptive, multicentre study. Patients meeting selection criteria aged between 18 and 65 years who visited participating community pharmacies to check any of five pre-MetS diagnostic factors were included. The study involved 23 community pharmacies in Catalonia (Spain). Detection criteria for pre-MetS were based on the WHO proposal following IDF and AHA/NHBI consensus. Cardiovascular risk (CVR) was calculated by Regicor and Score methods. Other variables studied were smoking habit, physical activity, body mass index (BMI), and pharmacological treatment of dyslipidemia and hypertension. The data were collected and analysed with the SPSS programme. Comparisons of variables were carried out using the Student"s T-test, Chi-Squared test or ANOVA test. Level of significance was 5% (0.05). Results: The overall prevalence of pre-MetS was 21.9% [95% CI 18.7-25.2]. It was more prevalent in men, 25.5% [95% CI 22.1-28.9], than in women, 18.6% [95% CI 15.5-21.7], and distribution increased with age. The most common risk factors were high blood pressure and abdominal obesity. About 70% of people with pre-MetS were sedentary and over 85% had a BMI ≥25 Kg/m2 . Some 22.4% had two metabolic criteria and 27.2% of patients with pre-MetS had no previous diagnosis. Conclusions: The prevalence of pre-MetS in our study (21.9%) was similar to that found in other studies carried out in Primary Care in Spain. The results of this study confirm emergent cardiometabolic risk factors such as hypertension, obesity and physical inactivity. Our study highlights the strategic role of the community pharmacy in the detection of pre-MetS in the apparently healthy population.
publishDate 2014
dc.date.none.fl_str_mv 2014
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/59463
url https://hdl.handle.net/2445/59463
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: http://dx.doi.org/10.1186/1471-2458-14-487
BMC Public Health, 2014, vol. 14, num. 487
http://dx.doi.org/10.1186/1471-2458-14-487
dc.rights.none.fl_str_mv cc-by (c) Via Sosa, Ma. de los Ángeles et al., 2014
http://creativecommons.org/licenses/by/3.0/es
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Via Sosa, Ma. de los Ángeles et al., 2014
http://creativecommons.org/licenses/by/3.0/es
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411751091503104
score 15,300724

Similares en LA Referencia